Crossmark

Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective

Crossref DOI link: https://doi.org/10.1016/j.eclinm.2024.102536

Published Print: 2024-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Gougis, Paul

Jochum, Floriane https://orcid.org/0000-0001-5009-3936
Abbar, Baptiste https://orcid.org/0000-0002-5907-8131
Dumas, Elise

Bihan, Kevin

Lebrun-Vignes, Bénédicte

Moslehi, Javid

Spano, Jean-Philippe

Laas, Enora

Hotton, Judicael

Reyal, Fabien

Hamy, Anne-Sophie

Salem, Joe-Elie https://orcid.org/0000-0002-0331-3307
Funding

Funding for this research was provided by:

Sanofi Pasteur SA

INCa

Universite Paris-Saclay
License Information

Text and Data Mining valid from 2024-04-01

Text and Data Mining valid from 2024-04-01

Version of Record valid from 2024-02-23
More Information

This article is maintained by: Elsevier

Article Title: Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective

Journal Title: eClinicalMedicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eclinm.2024.102536

Content Type: article

Copyright: © 2024 The Author(s). Published by Elsevier Ltd.